--- a
+++ b/clusters/9knumclustersv2/clust_1546.txt
@@ -0,0 +1,17 @@
+Patients should not receive immunization with attenuated live vaccine within one week of study entry or during study period
+Patients should not receive immunization with attenuated live vaccine within one week of study entry or during study period
+Immunization with any attenuated live vaccine within  week prior to initiating protocol-indicated treatment.
+Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
+Patients should not receive immunization with attenuated live vaccines within one week ( days) of study entry or during study period
+Patients should not receive immunization with attenuated live vaccines =<  days of study entry or during study period
+No immunizations with attenuated live vaccines within one week of study entry or during study period
+Immunization with a live/attenuated vaccine within  days of enrollment
+Patients should not receive immunization with attenuated live vaccines during study period or within  week of study entry
+Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
+Patients must not have received immunization with an attenuated live vaccine within seven days prior to registration nor have plans to receive such vaccination while on protocol treatment
+Immunization with any attenuated live vaccine within  week prior to registration
+Patients should not receive immunization with attenuated live vaccines during study period
+Receive immunization with attenuated live vaccines within one week of randomization or during the study period.
+Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
+Immunization with a live/attenuated vaccine within  days prior to conditioning
+Immunization with a live, attenuated vaccine within  weeks prior to study enrollment